Dinutuximab and Hemolytic uremic syndrome
Result of checking the interaction of drug Dinutuximab and disease Hemolytic uremic syndrome for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Atypical hemolytic uremic syndrome in the absence of documented infection and resulting in renal insufficiency, electrolyte abnormalities, anemia, and hypertension can occur in patients treated with dinutuximab. Atypical hemolytic uremic syndrome has recurred following rechallenge with dinutuximab. Permanently discontinue therapy and institute supportive management for signs of hemolytic uremic syndrome.